Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Jeri, Burr"'
Autor:
Mollie R. Cummins, Jeri Burr, Lisa Young, Sharon D. Yeatts, Dixie J. Ecklund, Brian E. Bunnell, Jamie P. Dwyer, John M. VanBuren
Publikováno v:
Journal of Clinical and Translational Science, Vol 7 (2023)
Abstract Introduction: During the COVID-19 pandemic, research organizations accelerated adoption of technologies that enable remote participation. Now, there’s a pressing need to evaluate current decentralization practices and develop appropriate
Externí odkaz:
https://doaj.org/article/f5b13f03006f4c978f6016910f53cc19
Autor:
Ann R. Johnson, Megan Kasimatis Singleton, Julie Ozier, Emily Serdoz, Jennifer G. Beadles, Janelle Maddox-Regis, Sarah Mumford, Jeri Burr, J. Michael Dean, Daniel E. Ford, Gordon R. Bernard
Publikováno v:
Journal of Clinical and Translational Science, Vol 6 (2022)
The Trial Innovation Network has established an infrastructure for single IRB review in response to federal policies. The Network’s single IRB (sIRBs) have successfully supported over 70 multisite studies via more than 800 reliance arrangements. Th
Externí odkaz:
https://doaj.org/article/5468b7195462473dac6a6dd39adf8777
Autor:
Rachel G. Greenberg, Lori Poole, Daniel E. Ford, Daniel Hanley, Harry P. Selker, Karen Lane, J. Michael Dean, Jeri Burr, Paul Harris, Consuelo H. Wilkins, Gordon Bernard, Terri Edwards, Daniel K. Benjamin
Publikováno v:
Journal of Clinical and Translational Science, Vol 5 (2021)
Abstract Introduction: The COVID-19 pandemic prompted the development and implementation of hundreds of clinical trials across the USA. The Trial Innovation Network (TIN), funded by the National Center for Advancing Translational Sciences, was an es
Externí odkaz:
https://doaj.org/article/efe59f03014e4fce9ab8d986b452ecbf
Autor:
Emily Stock, Yensy Zetino, Carolann Twelves, C. J. Jayachandran, Christopher J. L. Newth, Richard Holubkov, James W. Varni, Courtney Merritt, Lisa Steele, Ashley Wolfe, Ann Pawluszka, Mark W. Hall, Teresa Liu, Jeni Kwok, Michael J. Bell, Ranjit S. Chima, Murray M. Pollack, Elyse Tomanio, Samuel Sorenson, Hector R. Wong, Melanie Lulic, Erin Sullivan, Anil Sapru, Toni Yunger, Neda Ashtari, Robert A. Berg, Erin Stoneman, Michael W. Quasney, Andrew J. Yates, Todd C. Carpenter, Laura Benken, J. Carcillo, Aline B Maddux, Kathleen L. Meert, Kristi Flick, Anna E. Ratiu, Stephanie Bisping, Catherine Chen, Maggie Flowers, Whit Coleman, Diane Hession, Kelli A. Krallman, Jerry J. Zimmerman, John T. Berger, Rick Harrison, Deana Rich, Amy Yamakawa, Sabrina M. Heidemann, Athena F. Zuppa, Ruth Grosskreuz, Alan Abraham, Anne McKenzie, Josey Hensley, Wren Haaland, Patrick S. McQuillen, J. Michael Dean, Angie Webster, Peter M. Mourani, Jeri Burr, Diane Ladell, Kathryn B. Whitlock, Thomas P. Shanley, Andrew Nicklawsky, Alle Rutebemberwa, Joseph A. Carcillo, Ron W Reeder, Leighann Koch, David L. Wessel, Mary Ann DiLiberto, Derek Salud, Yamila Sierra, Julie McGalliard, Russell Banks
Publikováno v:
Pediatr Crit Care Med
OBJECTIVES To serially evaluate health-related quality of life during the first year after community-acquired septic shock in children with preexisting severe developmental disabilities and explore factors associated with health-related quality of li
Autor:
R. Whitney Coleman, Valeriya Vasenina, Stephanie Bisping, Ann Johnson, Jeri Burr, Jeffrey R. Botkin, J. Michael Dean
Publikováno v:
Ethics Hum Res
Implementing the National Institutes of Health's (NIH's) new single institutional review board (IRB) policy has caused a paradigm shift in IRB review across the country. IRBs and human research protection programs are looking more closely at their pr
Autor:
Douglas F. Willson, Allan Doctor, Jeri Burr, Angie Webster, J. Michael Dean, Robert F. Tamburro, Kanwaljeet J. S. Anand, Kathleen L. Meert, John T. Berger, Jerry J. Zimmerman, Tammara L. Jenkins, Michael J. Bell, Sabrina M. Heidemann, Christopher J. L. Newth, Heidi J. Dalton, Richard Holubkov, Carol Nicholson, Robert A. Berg, Thomas P. Shanley, Rick Harrison, Joseph A. Carcillo
Publikováno v:
Journal of Parenteral and Enteral Nutrition. 41:1325-1335
The pediatric Critical Illness Stress-induced Immune Suppression (CRISIS) trial compared the effectiveness of 2 nutraceutical supplementation strategies and found no difference in the development of nosocomial infection and sepsis in the overall popu
Autor:
Amy E. Clark, Jeri Burr, Teresa Liu, Thomas P. Shanley, Heidi J. Dalton, Tammara L. Jenkins, Richard Holubkov, Murray M. Pollack, Robert A. Berg, Allan Doctor, J. Michael Dean, John T. Berger, Kathleen L. Meert, Joseph A. Carcillo, David L. Wessel, Christopher J. L. Newth, Michele E. Villalobos, Jerry J. Zimmerman, Rick Harrison, Carol Nicholson, Douglas F. Willson, Kanwaljeet J. S. Anand, Ronald C. Sanders
Pertussis can cause life-threatening illness in infants. Data regarding neurodevelopment after pertussis remain scant. The aim of this study was to assess cognitive development of infants with critical pertussis 1 year after PICU discharge.Prospectiv
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::445c2bc9637c1306c319a2b49dc922b4
https://europepmc.org/articles/PMC5796844/
https://europepmc.org/articles/PMC5796844/
Autor:
Joseph A, Carcillo, J Michael, Dean, Richard, Holubkov, John, Berger, Kathleen L, Meert, K J S, Anand, Jerry, Zimmerman, Christopher J L, Newth, Rick, Harrison, Jeri, Burr, Douglas F, Willson, Carol, Nicholson, Tammara, Jenkins
Publikováno v:
Pediatric Critical Care Medicine. 13:165-173
Objectives: Nosocomial infection/sepsis occurs in up to 40% of children requiring long-term intensive care. Zinc, selenium, glutamine, metoclopramide (a prolactin secretalogue), and/or whey protein supplementation have been effective in reducing infe
Autor:
Elfriede Pahl, Lloyd Y. Tani, Grant H. Burch, E. Leigh Curtin, Bernie LaSalle, Rozsa Schlencker-Herceg, Robert E. Shaddy, Mark M. Boucek, Brett Sower, Lynn Mahony, Daphne T. Hsu, Jeri Burr
Publikováno v:
American Heart Journal. 144:383-389
Background Carvedilol is a medication with both β-receptor and α-receptor blocking properties that has been approved for the treatment of heart failure in adults. Little is known about its safety, efficacy, pharmacokinetics, and dosing profile in c
Publikováno v:
Current Therapeutic Research. 63:514-525
Background: Although the number of prospective pediatric drug trials has increased in the past few years, there are still fewer studies done in pediatric patients than in adults. Such studies are critical for determining the safety, efficacy, and app